| Investigator Silver Limited (IVR) ORDINARY FULLY PAID |
Materials |
$166 |
Trading Halt
|
27 Feb 2026 10:59AM |
$0.120 |
$0.064 |
fallen by
46.67%
|
|
IVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Investigator Silver Limited (ASX: IVR).
- Purpose includes announcements regarding Paris Silver Project DFS and Ore Reserve results.
- Material capital raising also involved.
- Halt to assist in continuous disclosure obligations.
- Trading halt effective until 3 March 2026 or upon announcement release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Netwealth Group Limited (NWL) ORDINARY FULLY PAID |
Financials |
$5,494 |
Application for quotation of securities - NWL
|
27 Feb 2026 10:58AM |
$25.740 |
$22.390 |
fallen by
13.01%
|
|
| Locality Planning Energy Holdings Limited (LPE) ORDINARY FULLY PAID |
Utilities |
$16 |
Half Yearly Report and Accounts
|
27 Feb 2026 10:57AM |
$0.105 |
$0.089 |
fallen by
15.24%
|
|
LPE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for ordinary activities decreased by 0.26% to $21,879,963.
- Net profit for the period decreased by 11.72% to $1,447,563.
- Net tangible assets per share decreased from $0.0651 to $0.0453.
- No dividends were paid during the reporting period.
- Financial statements reviewed by Grant Thornton.
- Compliance with Corporations Act 2001 and relevant accounting standards confirmed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prophecy International Holdings Limited (PRO) ORDINARY FULLY PAID |
Information Technology |
$6 |
Prophecy Completes Equity Raising
|
27 Feb 2026 10:55AM |
$0.110 |
$0.075 |
fallen by
31.82%
|
|
PRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed $0.975 million equity raising via share placement.
- Issued 6.5 million new shares at $0.15 per share.
- Share price set at 36.36% premium to last traded price.
- 40.76% premium to 10-day Volume Weighted Average Price.
- Funds used primarily for additional working capital.
- Placement completed in a single tranche.
- Shares issued under ASX Listing Rule 7.1.
- New shares expected to be allotted by 5th March 2026.
- Option for additional 3.5 million shares at $0.15 within nine months.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$20 |
Appendix 4G - Feb-26
|
27 Feb 2026 10:55AM |
$0.410 |
$0.370 |
fallen by
9.76%
|
|
| Scentre Group (SCG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$19,168 |
Change of Director's Interest Notice - Julie Coates
|
27 Feb 2026 10:54AM |
$3.810 |
$3.670 |
fallen by
3.67%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,158 |
Change of Director's Interest Notice - S Adam-Gedge
|
27 Feb 2026 10:54AM |
$6.105 |
$5.210 |
fallen by
14.66%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$20 |
Corporate Governance Statement - Feb-26
|
27 Feb 2026 10:52AM |
$0.410 |
$0.370 |
fallen by
9.76%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$20 |
IMEXHS FY25 Investor Presentation
|
27 Feb 2026 10:51AM |
$0.410 |
$0.370 |
fallen by
9.76%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 10% year-on-year to $29 million.
- Underlying EBITDA improved to $1.6 million from $0.5 million.
- Annual Recurring Revenue (ARR) increased by 16% to $34.8 million.
- One-off goodwill impairment charge of $1.7 million was taken.
- Software revenue grew by 12%, while Radiology Services grew by 8%.
- Operational improvements include AI-driven cost-saving measures.
- Disciplined approach to client portfolio management was maintained.
- Plans to expand software growth and improve margins through automation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austin Metals Limited (AYT) ORDINARY FULLY PAID |
Materials |
$7 |
Cleansing Notice
|
27 Feb 2026 10:51AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Advance ZincTek Limited (ANO) ORDINARY FULLY PAID |
Materials |
$47 |
Half Yearly Report and Accounts
|
27 Feb 2026 10:49AM |
$0.975 |
$0.750 |
fallen by
23.08%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$195 |
Increased interim dividend, strong total shareholder return
|
27 Feb 2026 10:49AM |
$1.020 |
$0.990 |
fallen by
2.94%
|
|
WMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Increased interim dividend declared at 3.0 cents per share, partially franked at 60%
- Annualized interim dividend yield of 5.9% and grossed-up yield of 7.4%
- Strong total shareholder return of 9.4% for H2 2025, or 10.8% including franking credits
- Investment portfolio increased by 4.9% in H2 2025
- Wilson Asset Management has managed a 9.0% annualized portfolio increase since October 2020
- Continued growth expected with upcoming private equity exits
- Focus on stable, inflation-linked income with private equity and infrastructure investments
- Upside in water investments due to Australian market conditions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$20 |
IMEXHS Reports FY25 Results
|
27 Feb 2026 10:48AM |
$0.410 |
$0.370 |
fallen by
9.76%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- IMEXHS Limited reported FY25 revenue of $29.0 million.
- Underlying EBITDA rose to $1.6 million from $0.5 million.
- Annualised Recurring Revenue (ARR) reached $34.8 million.
- Processed 8.2 million studies with 99.8% platform uptime.
- Software ARR grew to $11.8 million, a 19% increase.
- Strategic enterprise wins and expanded partner programs.
- Improved working capital, reduced debt, and increased cash.
- IMEXHS expects to exceed FY25 financial performance in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advance ZincTek Limited (ANO) ORDINARY FULLY PAID |
Materials |
$47 |
Appendix 4D
|
27 Feb 2026 10:48AM |
$0.975 |
$0.750 |
fallen by
23.08%
|
|
ANO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 16.5% to $6,662,000.
- Net profit attributable to members rose by 21.38% to $1,158,000.
- Net tangible assets per share increased to 44.49 cents.
- Basic earnings per share increased to 1.84 cents.
- No interim dividend will be paid for this period.
- No changes in control over subsidiaries.
- No control gained or lost over entities during this period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$7 |
Corporate Governance Statement & Appendix 4G
|
27 Feb 2026 10:47AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$20 |
Appendix 4E & Annual Report 2025
|
27 Feb 2026 10:47AM |
$0.410 |
$0.370 |
fallen by
9.76%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss increased by 11% to A$4.94 million.
- Revenue from ordinary activities decreased significantly.
- Successful Phase III clinical trial of Felix™ System.
- CE Mark application submitted for European market entry.
- Strategic focus on commercialisation and international expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$25 |
Notice of Proposed Share Consolidation
|
27 Feb 2026 10:46AM |
$0.001 |
$0.025 |
risen by
2,400%
|
|
OVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidation ratio 20:1
- Requires shareholder approval at EGM on 30 March 2026
- Aimed at improving capital structure
- Options to be consolidated with adjusted exercise prices
- Fractional entitlements to be rounded up
- Indicative timetable provided
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$7 |
Appendix 4E & 2025 Annual Report
|
27 Feb 2026 10:46AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
ENL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to US$3.8 million for 2025.
- Loss after tax was US$13.4 million.
- Laitek acquisition expanded revenue base.
- Strategic partnership with GE Healthcare.
- Focus on AI-driven data governance and usability.
- Capital raised to support growth and commercialization.
- Audited financial report with unmodified opinion.
- No dividends declared for the current period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$40 |
NTA at 13.02.2026 Pre-tax 1.3684 and Post-tax 1.3091
|
27 Feb 2026 10:46AM |
$1.195 |
$1.315 |
risen by
10.04%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$14 |
Appendix 4D - Half-year Financial Report - 31 December 2025
|
27 Feb 2026 10:45AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
MEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Memphasys Limited recorded a net loss after tax of $2,338,819 for the half-year ended 31 December 2025.
- Operating revenue of $12,406 was recognized during the period due to the commencement of commercial invoicing following regulatory approvals.
- Orders from Europe and the MENA region amounted to $94,008, with additional orders from Japan valued at $17,558.
- No impairment of intangible assets was recognized, compared to an impairment of $896,400 in the prior period.
- Employee benefits expenses increased due to termination payments and restructuring costs.
- Compliance, audit, tax, and legal expenses increased significantly.
- Research and development expenses decreased as the company shifted focus to commercial execution.
- The company completed capital raising activities generating $1.9 million in gross proceeds.
- The Felix™ System achieved global regulatory milestones, including UK and TGA approvals.
- The company executed a five-year supply agreement in Europe worth approximately A$925,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rectifier Technologies Ltd (RFT) ORDINARY FULLY PAID |
Industrials |
$6 |
Half Yearly Report and Accounts
|
27 Feb 2026 10:44AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
RFT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 61.4% to $3,889,883.
- Loss after tax was $2,351,869, down from a profit of $882,868.
- Significant revenue drop in the European market.
- No dividends declared during the period.
- Total assets remained at approximately $27.66 million.
- Auditors issued an unqualified conclusion for the financial statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$25 |
Notice of Extraordinary General Meeting/Proxy Form
|
27 Feb 2026 10:43AM |
$0.001 |
$0.025 |
risen by
2,400%
|
|
OVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Notice of Extraordinary General Meeting for Ovanti Limited
- Meeting scheduled for 30 March 2026 in Sydney, NSW
- Instructions for lodging proxy forms online, by mail, in person, or via email
- Resolutions include ratification of prior issues, share consolidation, and future share issuance
- Shareholders must provide voting directions or authorize the Chair to vote
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$662 |
2025 Full Year Results, strong TSR and increased FF divs
|
27 Feb 2026 10:41AM |
$1.650 |
$1.650 |
fallen by
0%
|
|
FGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Full-year results show a 16.2% total shareholder return for FY2025.
- Declared fully franked full-year dividend of 8.0 cents per share.
- Special fully franked dividend of 3.0 cents per share announced.
- Investment portfolio managed by 16 leading pro bono fund managers.
- 3-year investment portfolio performance was 18.1% per annum.
- Operating profit before tax for FY2025 was $67.9 million.
- Portfolio is diversified across sectors and regions, underweight in mega-cap tech.
- Total of $50.5 million donated to mental health initiatives since inception.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$268 |
GVF delivers another half year of healthy returns
|
27 Feb 2026 10:39AM |
$1.365 |
$1.325 |
fallen by
2.93%
|
|
GVF - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating profit before tax of $11.5M.
- Adjusted pre-tax NTA increased by 4.4%.
- Discount capture strategy added 3% to returns.
- Fully franked dividend of 3.3 cents per share declared.
- Total grossed-up dividends since IPO match original share price.
- Dividend reinvestment plan provides lowest reinvestment price.
- FY2026 full year dividend expected to match interim dividend.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$268 |
Dividend/Distribution - GVF
|
27 Feb 2026 10:38AM |
$1.365 |
$1.325 |
fallen by
2.93%
|
|
Call 1300 880 160
Start a chat
Schedule a call
